Literature DB >> 17515878

Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma.

Christian L Roth1, Donald H Hunneman, Ursel Gebhardt, Birgit Stoffel-Wagner, Thomas Reinehr, Hermann L Müller.   

Abstract

Severe obesity is a major problem in patients suffering from craniopharyngioma (CP), a benign tumor located in pituitary and hypothalamic regions. In this study, the hypothesis that hypothalamic damage leads to a reduction in overall sympathetic tone was tested. Catecholamines, as well as their metabolites homovanillic acid (HVA) and vanillylmandelic acid (VMA), markers of catecholamine turnover, were measured in morning voided urine of 109 patients participating in a German pediatric CP study, and their physical activity was analyzed using a questionnaire. HVA and VMA results were compared with age-matched HVA and VMA in urine of patients proven to not have a catecholamine-secreting tumor. Patients with the most severe obesity displayed the lowest urine HVA and VMA values. Patients with hypothalamic CP had 3.2-fold higher BMI values (p<0.0001), lower HVA (0.72-fold, p<0.001), and VMA (0.84-fold, p<0.01) values, and significantly lower activity scores than those without hypothalamic involvement, but their epinephrine- and norepinephrine/creatinine ratios were not significantly different, possibly due to low levels. The low HVA and VMA values suggest decreased sympathetic outflow contributing to reduced physical activity and severe obesity, especially in patients with a hypothalamic tumor. In further studies investigating treatment options for hypothalamic obesity, disturbed sympathetic tone should be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515878     DOI: 10.1203/pdr.0b013e3180332cd6

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  29 in total

1.  Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.

Authors:  Gabrielle Page-Wilson; Sharon L Wardlaw; Alexander G Khandji; Judith Korner
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 2.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

3.  A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients.

Authors:  Christian L Roth; James E Blevins; Melissa Ralston; Clinton Elfers; Kayoko Ogimoto; Karl J Kaiyala; Gregory J Morton
Journal:  Pediatr Res       Date:  2011-03       Impact factor: 3.756

Review 4.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

5.  Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series.

Authors:  Christian Denzer; Friederike Denzer; Belinda S Lennerz; Heike Vollbach; Robert H Lustig; Martin Wabitsch
Journal:  Obes Facts       Date:  2019-03-07       Impact factor: 3.942

Review 6.  Childhood craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

Review 7.  Malnutrition and obesity in pediatric oncology patients: causes, consequences, and interventions.

Authors:  Erica Co-Reyes; Rhea Li; Winston Huh; Joya Chandra
Journal:  Pediatr Blood Cancer       Date:  2012-09-04       Impact factor: 3.167

Review 8.  Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.

Authors:  Michelle Lee; Judith Korner
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

9.  Energy expenditure in obesity associated with craniopharyngioma.

Authors:  Roy J Kim; Rachana Shah; Andy M Tershakovec; Babette S Zemel; Leslie N Sutton; Adda Grimberg; Thomas Moshang
Journal:  Childs Nerv Syst       Date:  2010-01-27       Impact factor: 1.475

10.  Preoperative BMI Predicts Postoperative Weight Gain in Adult-onset Craniopharyngioma.

Authors:  Daisy Duan; Leen Wehbeh; Debraj Mukherjee; Amir H Hamrahian; Fausto J Rodriguez; Sachin Gujar; Adham M Khalafallah; Camille Hage; Patrizio Caturegli; Gary L Gallia; Rexford S Ahima; Nisa M Maruthur; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.